Oxford Nanopore Technologies Ltd – Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network

/in , , , /by

The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including […]

Read more →

Jury invalidates PacBio’s patents in U.S. patent trial against Oxford Nanopore

/in , /by

After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences (“PacBio”) in this litigation. During the trial, the jury heard evidence that PacBio had never performed nanopore sequencing, before or after they filed patents that allegedly cover nanopore […]

Read more →

Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies

/in , , /by

Menlo Park – Pacific Biosciences of California, Inc., a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings. Although the jury sided with Pacific Biosciences […]

Read more →